These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20958900)

  • 1. Use of oral ketamine in a patient with systemic mastocytosis.
    Yoong J; Le B
    Intern Med J; 2010 Oct; 40(10):735-6. PubMed ID: 20958900
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic mastocytosis - the importance of looking within bone marrow fragments: AJH Educational Material.
    Bain BJ; Khoder A; Milojkovic D; Bernard T
    Am J Hematol; 2014 Jan; 89(1):109-10. PubMed ID: 24123109
    [No Abstract]   [Full Text] [Related]  

  • 3. Lenalidomide therapy in systemic mastocytosis.
    Kluin-Nelemans HC; Ferenc V; van Doormaal JJ; van Iperen C; Peters WG; Akin C; Valent P
    Leuk Res; 2009 Mar; 33(3):e19-22. PubMed ID: 18644623
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
    Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
    Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic mastocytosis. Osteoporotic fracture as a manifestation].
    Chandesris MO; Damaj G; Barete S; Lortholary O; Hermine O
    Rev Prat; 2011 Oct; 61(8):1047-50. PubMed ID: 22135963
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic mastocytosis associated with acute myeloid leukaemia.
    Fong C; Tong M
    Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
    [No Abstract]   [Full Text] [Related]  

  • 7. Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosis.
    Rohr SM; Rich MW; Silver KH
    Ann Emerg Med; 2005 Jun; 45(6):592-4. PubMed ID: 15940090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of aspirin administration in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):122-4. PubMed ID: 19429499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis and diffuse large B-cell lymphoma, an unlikely combination.
    Schipper EM; Posthuma W; Snieders I; Brouwer RE
    Neth J Med; 2011 Mar; 69(3):132-4. PubMed ID: 21444939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple life-threatening fainting episodes: fatal systemic mastocytosis.
    Confino-Cohen R; Zilber M; Goldberg A
    Isr Med Assoc J; 2003 Oct; 5(10):752-3. PubMed ID: 14719479
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
    Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
    Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
    Lakartidningen; 2008 Nov 12-18; 105(46):3341-4, 3346-7. PubMed ID: 19062626
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic Mastocytosis: documented pathologic response to imatinib.
    Gollard RP; Ruemmler-Fish C; Garcia D
    Eur J Haematol; 2007 Oct; 79(4):367-8. PubMed ID: 17655701
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
    Angus J; Leach IH; Grant J; Ravenscroft JC
    Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive systemic mastocytosis: is there a role for trisomy 8?
    Callera F; Chauffaille Mde L
    Leuk Res; 2005 Apr; 29(4):471-3. PubMed ID: 15725484
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens.
    Krauth MT; Födinger M; Rebuzzi L; Greul R; Chott A; Valent P
    Haematologica; 2007 Dec; 92(12):e126-9. PubMed ID: 18055976
    [No Abstract]   [Full Text] [Related]  

  • 17. Midostaurin (Rydapt) for AML and advanced systemic mastocytosis.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):e140. PubMed ID: 28787746
    [No Abstract]   [Full Text] [Related]  

  • 18. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic mastocytosis.
    Williams A; Krishna T; Frew A
    Lancet; 2002 Nov; 360(9345):1611. PubMed ID: 12443644
    [No Abstract]   [Full Text] [Related]  

  • 20. Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
    King JJ; Crawford EA; Iwenofu OH; Fox EJ
    Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.